Finance

Beta
Lists
HLS:TSE
HLS Therapeutics Inc
CA$4.41
-1.34%
(-0.060) 1D
Jun 8, 4:00:00 PM GMT-4  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for HLS...
Open
CA$4.40
High
CA$4.41
Low
CA$4.35
Mkt. cap
137.92M
Avg. vol.
5.86K
Volume
3.01K
52-wk high
CA$5.76
52-wk low
CA$4.22
EPS
-CA$0.46
Beta
0.54
Shares outstanding
31.27M
No. of employees
85
Open
CA$4.40
High
CA$4.41
Low
CA$4.35
Mkt. cap
137.92M
Avg. vol.
5.86K
Volume
3.01K
52-wk high
CA$5.76
52-wk low
CA$4.22
EPS
-CA$0.46
Beta
0.54
Shares outstanding
31.27M
No. of employees
85
Analyst outlook
Analyst Ratings
Based on 3 analysts giving stock ratings to HLS in the past 3 months
Buy
Buy
1
Hold
2
Sell
0
12 month forecast
Based on 3 Wall Street analysts offering 12 month price targets for HLS in the last 3 months.
Highest
Current CA$4.41
CA$12.00 (+172.11%)
Average
CA$7.15 (+62.13%)
Lowest
CA$4.45 (+0.91%)
News stories
From sources across the web
About HLS Therapeutics Inc
CEO-
Employees85
Founded2014
Headquarters-
SectorPharmaceutical industry
Last report
May 15, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
-$0.07 / -$0.12
+41.67%beat
Revenue / Est. (USD)
12.86M / 13.03M
-1.30%miss
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
14.17M
13.51M
15.20M
12.86M
Cost of goods sold
3.87M
3.81M
4.28M
4.19M
Cost of revenue
3.87M
3.81M
4.28M
4.19M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5.13M
4.78M
5.21M
5.21M
Operating expense
11.08M
11.08M
10.68M
10.89M
Total operating expenses
14.95M
14.88M
14.96M
15.08M
Operating income
-778.00K
-1.37M
237.00K
-2.22M
Other non operating income
-31.00K
-534.00K
-517.00K
-87.00K
EBT including unusual items
-2.50M
-3.94M
-1.98M
-2.30M
EBT excluding unusual items
-2.50M
-3.94M
-1.98M
-2.30M
Income tax expense
242.00K
-17.00K
-647.00K
2.00K
Effective tax rate
-9.68%
0.43%
32.64%
-0.09%
Other operating expenses
-
-
-
-
Net income
-2.74M
-3.92M
-1.34M
-2.30M
Net profit margin
-19.34%
-29.00%
-8.79%
-17.86%
Earnings per share
-0.09
-0.12
-0.04
-0.07
Interest and investment income
33.00K
24.00K
18.00K
12.00K
Interest expense
-1.73M
-2.44M
-897.00K
-801.00K
Net interest expenses
-1.70M
-2.42M
-879.00K
-789.00K
Depreciation and amortization charges
5.48M
5.51M
5.46M
5.54M
EBITDA
4.70M
4.14M
5.18M
3.32M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more